Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy

BACKGROUND: The Birch Allergoid, Tyrosine Adsorbate, Monophosphoryl Lipid A (POLLINEX (®) Quattro Plus 1.0 ml Birch 100%) is an effective, well‐tolerated short course subcutaneous immunotherapy. We performed 2 phase II studies to determine its optimal cumulative dose. METHODS: The studies were condu...

Descripción completa

Detalles Bibliográficos
Autores principales: Worm, M., Higenbottam, T., Pfaar, O., Mösges, R., Aberer, W., Gunawardena, K., Wessiepe, D., Lee, D., Kramer, M. F., Skinner, M., Lees, B., Zielen, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175210/
https://www.ncbi.nlm.nih.gov/pubmed/29779247
http://dx.doi.org/10.1111/all.13478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175210/
https://www.ncbi.nlm.nih.gov/pubmed/29779247
http://dx.doi.org/10.1111/all.13478

Ejemplares similares